Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04745884 · ClinicalTrials.gov registry record · NA
A Study to Detect Progression of Mass Effect From Unilateral Brain Lesions
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04745884: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT04745884 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04745884, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this research is to gather information on the safety and effectiveness of the Brain4Care device for measuring intracranial pressure without invasive procedures.
Primary Outcome
Functional outcome was assessed using the Modified Rankin Scale (mRS) which assesses functional outcomes in patients recovering from strokes. It consists of a 7-point ordinal scale ranging from 0 to 6 where 0=no symptoms and 6=dead with higher scores indicating a worse functional outcome.
Interventions
- DEVICE Non-invasive bilateral monitoring of ICP waveform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-02-04 |
| Est. Completion | 2024-12-02 |
| Phase | NA |
Why NCT04745884 stopped before completion
NCT04745884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Non-invasive bilateral monitoring of ICP waveform is the first listed.
NCT04745884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04745884 about?
NCT04745884 is a clinical study titled "A Study to Detect Progression of Mass Effect From Unilateral Brain Lesions". The purpose of this research is to gather information on the safety and effectiveness of the Brain4Care device for measuring intracranial pressure without invasive procedures.
What is the current status of trial NCT04745884?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-02-04. Estimated completion is 2024-12-02.
What interventions are being tested in trial NCT04745884?
The interventions under investigation include: Non-invasive bilateral monitoring of ICP waveform (DEVICE).
Who is sponsoring clinical trial NCT04745884?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04745884's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI